Curaleaf (OTCMKTS:CURLF – Get Free Report) had its target price hoisted by equities researchers at Needham & Company LLC from $5.25 to $6.25 in a report released on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Needham & Company LLC’s target price points to a potential upside of 13.64% from the stock’s previous close.
Curaleaf Stock Up 3.8 %
Shares of OTCMKTS CURLF opened at $5.50 on Friday. The company has a market capitalization of $3.56 billion, a P/E ratio of -14.10 and a beta of 1.29. Curaleaf has a 52-week low of $2.36 and a 52-week high of $6.40. The company has a debt-to-equity ratio of 0.87, a quick ratio of 0.41 and a current ratio of 0.85. The company’s 50 day moving average price is $5.06 and its 200-day moving average price is $4.49.
Curaleaf (OTCMKTS:CURLF – Get Free Report) last issued its quarterly earnings results on Wednesday, March 6th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.04. The firm had revenue of $345.27 million for the quarter, compared to the consensus estimate of $336.64 million. Curaleaf had a negative net margin of 20.77% and a negative return on equity of 12.93%. Equities analysts forecast that Curaleaf will post -0.18 earnings per share for the current year.
About Curaleaf
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Read More
- Five stocks we like better than Curaleaf
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Will the Surge in GameStop Stock Spark a New Meme Craze?
- ETF Screener: Uses and Step-by-Step Guide
- 3 Stocks Nancy Pelosi Has Been Buying
- What is a SEC Filing?
- Will the Biotech Sector Shift From Lagger to Leader?
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.